GENSCRIPT BIO
Biotechnology · Healthcare
CEO
1 appearance
Latest appearance 2026-03-16
CEO
GENSCRIPT BIO
Equibles does not estimate personal net worth.
Sherry is recorded as CEO at GENSCRIPT BIO. Sherry has spoken on 1 earnings call across 1 company, most recently for GENSCRIPT BIO on March 16, 2026. GENSCRIPT BIO is classified in the Biotechnology industry within the Healthcare sector.
“In 2025, Jens Group Group delivered accelerated growth despite navigating a complex geopolitical and macroeconomic. Our success was powered by leveraging our global operations, robust management frameworks, and technological expertise, allowing us to transform challenges into opportunities.”
GENSCRIPT BIO
CEO
Transcript header (unverified)
GENSCRIPT BIO
Biotechnology · Healthcare
CEO
2025 Annual Results Conference
GENSCRIPT BIO